Abstract
Because most of the current therapies for the treatment of mental disorders such as depression are cognitive behavioral therapy, the treatment time is too long for people with major depression who face serious threats of suicide, and the symptoms cannot be alleviated in time when the onset of this kind of treatment is not suitable for them. Medication is another option for treatment, although in the case of depression that resists therapy, a type of severe depression, few antidepressants are effective to them. If left untreated, this type of depression might result in suicide since those who experience it have little desire to live and are gloomy. Therefore, people with treatment-resistant depression have a higher suicide rate. In this paper, esketamine (a kind of ketamine), one of the few fast antidepressant drugs that can play a role, will be mentioned, and the therapeutic effect and safety of such drugs will be analyzed, and the efficacy of different people will be compared in depth. In addition, there is a wonder drug in the development process - ayahuasca will be mentioned and compared with ketamine drugs. It becomes clear that the research presented in this essay still has some weaknesses. The areas that need to be improved will next be demonstrated using examples. The usage and inadequacy of ayahuasca will also be assessed in this essay at the same time.
Publisher
Darcy & Roy Press Co. Ltd.